Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors

What are you looking for?

Home

Top menu

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Kingdom
  • United States
  • Venezuela
  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Injectable Aesthetics
    • Dermatological Skincare
    • Therapeutic Dermatology
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2024
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Podcasts
  • Innovation
    • Skin Science by Galderma
    • Bringing innovation to life
    • Partnering
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • For society
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Investors

Galderma launches "Scratch Resistance" campaign to validate the physical and emotional burdens of atopic dermatitis

Press release

Galderma’s Differin is helping destigmatize acne care with first in category Roblox experience

Press release

Galderma launches Cetaphil Gentle Exfoliating line with Gen-Z it-girl Katie Fang

Press release

Galderma introduces high potency Cetaphil serums designed for sensitive skin

Press release

Galderma launches advanced new serum with ALASTIN Skincare® - C-RADICAL Defense Antioxidant Serum

Press release

Powered by Peptides: Galderma introduces Cetaphil Healthy Renew, a retinol alternative skincare range

Press release

Galderma receives FDA approval for its newest hyaluronic acid filler, Restylane® Eyelight™

Press release

Galderma receives FDA approval for Sculptra® for cheek wrinkles

Press release

Galderma launches FACE by Galderma™, a cutting-edge aesthetic visualization tool that simulates injectable treatment results in real-time

Press release

Cetaphil Celebrates Global Initiative Highlighting Sensitive Skin with a Month of Skin Science Education

Press release

Pagination

  • Next page Next Page
Subscribe to U.S. release
  1. Home
  2. U.S. release

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2025

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back